Transforming hypercholesterolemia management: Spotlight on PCSK9 peptide vaccines
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a therapeutic target for dyslipidemia and atherosclerotic cardiovascular disease (ASCVD). Two recent studies published by Fang et al.1 and Zhang et al.2 in Cell Reports Medicine and Cell Reports, respectively, show the efficacy of peptide vacc...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2024-09-01
|
| Col·lecció: | Cell Reports Medicine |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2666379124004531 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|